Literature DB >> 23462262

Internal mammary artery harvesting influences antibiotic penetration into presternal tissue.

Martin Andreas1, Markus Zeitlinger, Martina Hoeferl, Walter Jaeger, Daniel Zimpfer, Joerg-Michael Hiesmayr, Guenther Laufer, Doris Hutschala.   

Abstract

BACKGROUND: Internal mammary artery (IMA) harvesting for coronary artery bypass grafting (CABG) influences tissue perfusion and represents a risk factor for deep sternal wound infection (DSWI). Cephalosporins are routinely administered for prophylaxis during cardiac operations to decrease perioperative wound infections. We hypothesized that mammary artery preparation impairs antibiotic penetration into presternal tissue during CABG.
METHODS: Eight patients undergoing skeletonized left mammary artery harvesting for CABG were included. Standard antibiotic prophylaxis was administered: 4 g of cefazolin before skin incision and an additional 2 g during skin closure. Concentrations of cefazolin were measured in subcutaneous tissue on the presternal right and left sides (surgically affected) after sternotomy and additionally in subcutaneous tissue on the thigh (surgically unaffected) by microdialysis over a 10-hour period.
RESULTS: Mean peak tissue concentration and the area under the curve (AUC) on the left sternal side were significantly reduced compared with the right side and compared with the thigh (mean peak concentration, 13.1±5.8 versus 24.1±4.7 and 27.8±9.7 μg/mL; p=0.005 and p=0.013; AUC 74.2±31.0 versus 110.4±25.0 and 140.3±46.3 μg×hours per milliliter; p=0.004 and p=0.002). Mean subcutaneous concentrations of cefazolin on the left sternal side exceeded the minimal inhibitory concentration (MIC90) of Staphylococcus epidermidis of 4 μg/mL in only 5 of 8 (37.5%) patients after 5 hours.
CONCLUSIONS: IMA harvesting significantly impairs local antibiotic penetration during CABG. Common antibiotic dosing schemas should be reevaluated in this cardiac surgical setting.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462262     DOI: 10.1016/j.athoracsur.2012.10.088

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model.

Authors:  Mikkel Tøttrup; Bo M Bibby; Tore F Hardlei; Mats Bue; Sigrid Kerrn-Jespersen; Kurt Fuursted; Kjeld Søballe; Hanne Birke-Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

2.  Cefazolin Concentration in the Mediastinal Adipose Tissue of Patients Undergoing Cardiac Surgery.

Authors:  Rodrigo Mezzalira Tchaick; Michel Pompeu Barros Oliveira Sá; Fernando Ribeiro de Moraes Figueira; Kilma Coelho Paz; Álvaro Antonio Bandeira Ferraz; Fernando Ribeiro de Moraes
Journal:  Braz J Cardiovasc Surg       Date:  2017 Jul-Aug

3.  Pharmacokinetics of cefuroxime in porcine cortical and cancellous bone determined by microdialysis.

Authors:  Mikkel Tøttrup; Tore Forsingdal Hardlei; Michael Bendtsen; Mats Bue; Birgitte Brock; Kurt Fuursted; Kjeld Søballe; Hanne Birke-Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

4.  Skeletal muscle and plasma concentrations of cefazolin during complex paediatric spinal surgery.

Authors:  A S Himebauch; W N Sankar; J M Flynn; M T Sisko; G S Moorthy; J S Gerber; A F Zuppa; E Fox; J P Dormans; T J Kilbaugh
Journal:  Br J Anaesth       Date:  2016-07       Impact factor: 9.166

5.  Deep sternal wound infection after cardiac surgery: Evidences and controversies.

Authors:  Paolo Cotogni; Cristina Barbero; Mauro Rinaldi
Journal:  World J Crit Care Med       Date:  2015-11-04

Review 6.  Poststernotomy mediastinitis: a classification to initiate and evaluate reconstructive management based on evidence from a structured review.

Authors:  Jan J van Wingerden; Dirk T Ubbink; Chantal M A M van der Horst; Bas A J M de Mol
Journal:  J Cardiothorac Surg       Date:  2014-11-23       Impact factor: 1.637

7.  Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.

Authors:  Keso Skhirtladze-Dworschak; Doris Hutschala; Georg Reining; Peter Dittrich; Anna Bartunek; Martin Dworschak; Edda M Tschernko
Journal:  Br J Clin Pharmacol       Date:  2019-02-13       Impact factor: 4.335

8.  Plasma and Lung Tissue Pharmacokinetics of Ceftaroline Fosamil in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass: an In Vivo Microdialysis Study.

Authors:  M Edlinger-Stanger; V Al Jalali; M Andreas; W Jäger; M Böhmdorfer; M Zeitlinger; D Hutschala
Journal:  Antimicrob Agents Chemother       Date:  2021-07-19       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.